336 related articles for article (PubMed ID: 26484996)
1. Considerations in Patients With Cardiac Implantable Electronic Devices at End of Life.
Gura MT
AACN Adv Crit Care; 2015; 26(4):356-63. PubMed ID: 26484996
[TBL] [Abstract][Full Text] [Related]
2. Ethical and legal views regarding deactivation of cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy.
Kramer DB; Kesselheim AS; Salberg L; Brock DW; Maisel WH
Am J Cardiol; 2011 Apr; 107(7):1071-1075.e5. PubMed ID: 21296323
[TBL] [Abstract][Full Text] [Related]
3. Deactivation of pacemakers and implantable cardioverter-defibrillators.
Kramer DB; Mitchell SL; Brock DW
Prog Cardiovasc Dis; 2012; 55(3):290-9. PubMed ID: 23217433
[TBL] [Abstract][Full Text] [Related]
4. Withdrawal of cardiac medications and devices.
Wiegand DL; Kalowes PG
AACN Adv Crit Care; 2007; 18(4):415-25. PubMed ID: 17978616
[TBL] [Abstract][Full Text] [Related]
5. Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness. An ethical distinction.
Kay GN; Bittner GT
Circ Arrhythm Electrophysiol; 2009 Jun; 2(3):336-9; discussion 339. PubMed ID: 19808484
[No Abstract] [Full Text] [Related]
6. Ethical considerations for discontinuing pacemakers and automatic implantable cardiac defibrillators at the end-of-life.
Morgenweck CJ
Curr Opin Anaesthesiol; 2013 Apr; 26(2):171-5. PubMed ID: 23403711
[TBL] [Abstract][Full Text] [Related]
7. Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating permanent pacemaker in patients with terminalillness. Patient autonomy is paramount.
Zellner RA; Aulisio MP; Lewis WR
Circ Arrhythm Electrophysiol; 2009 Jun; 2(3):340-4; discussion 340. PubMed ID: 19808485
[No Abstract] [Full Text] [Related]
8. Ethical analysis of withdrawal of pacemaker or implantable cardioverter-defibrillator support at the end of life.
Mueller PS; Hook CC; Hayes DL
Mayo Clin Proc; 2003 Aug; 78(8):959-63. PubMed ID: 12911044
[TBL] [Abstract][Full Text] [Related]
9. [Implantable cardioverter-defibrillator deactivation at the end of life: ethical, clinical and communication issues].
Romanò M; Piga MA; Bertona R; Negro R; Ruggeri C; Zorzoli F; Villani R
G Ital Cardiol (Rome); 2017 Feb; 18(2):139-149. PubMed ID: 28398367
[TBL] [Abstract][Full Text] [Related]
10. Ethical considerations for turning off pacemakers and defibrillators.
Karches KE; Sulmasy DP
Card Electrophysiol Clin; 2015 Sep; 7(3):547-55. PubMed ID: 26304534
[TBL] [Abstract][Full Text] [Related]
11. Deactivating cardiac pacemakers and implantable cardioverter defibrillators in terminally ill patients.
Beca JP; Rosselot E; Asenjo R; Anguita V; Quevedo R
Camb Q Healthc Ethics; 2009; 18(3):236-40. PubMed ID: 19460224
[No Abstract] [Full Text] [Related]
12. Management of cardiac electrical implantable devices in patients nearing the end of life or requesting withdrawal of therapy: review of the Heart Rhythm Society 2010 consensus statement.
Kramer DB; Ottenberg AL; Mueller PS
Pol Arch Med Wewn; 2010 Dec; 120(12):497-502. PubMed ID: 21178906
[TBL] [Abstract][Full Text] [Related]
13. Cardiac Implantable Electronic Devices and End-of-Life Care: An Australian Perspective.
Alhammad NJ; O'Donnell M; O'Donnell D; Mariani JA; Gould PA; McGavigan AD
Heart Lung Circ; 2016 Aug; 25(8):814-9. PubMed ID: 27320854
[TBL] [Abstract][Full Text] [Related]
14. Pacemaker deactivation: withdrawal of support or active ending of life?
Huddle TS; Amos Bailey F
Theor Med Bioeth; 2012 Dec; 33(6):421-33. PubMed ID: 22351107
[TBL] [Abstract][Full Text] [Related]
15. The deactivation of implantable cardioverter-defibrillators: medical, ethical, practical, and legal considerations.
Carlsson J; Paul NW; Dann M; Neuzner J; Pfeiffer D
Dtsch Arztebl Int; 2012 Aug; 109(33-34):535-41. PubMed ID: 23152737
[TBL] [Abstract][Full Text] [Related]
16. Ethical and legal views of physicians regarding deactivation of cardiac implantable electrical devices: a quantitative assessment.
Kramer DB; Kesselheim AS; Brock DW; Maisel WH
Heart Rhythm; 2010 Nov; 7(11):1537-42. PubMed ID: 20650332
[TBL] [Abstract][Full Text] [Related]
17. Autonomy versus futility? Barriers to good clinical practice in end-of-life care: a Queensland case.
Lawrence S; Willmott L; Milligan E; Winch S; White B; Parker M
Med J Aust; 2012 Apr; 196(6):404-5. PubMed ID: 22471543
[TBL] [Abstract][Full Text] [Related]
18. Treating or Killing? The Divergent Moral Implications of Cardiac Device Deactivation.
Pilkington BC
J Med Philos; 2020 Jan; 45(1):28-41. PubMed ID: 31889187
[TBL] [Abstract][Full Text] [Related]
19. The ethical and legal implications of deactivating an implantable cardioverter-defibrillator in a patient with terminal cancer.
England R; England T; Coggon J
J Med Ethics; 2007 Sep; 33(9):538-40. PubMed ID: 17761824
[TBL] [Abstract][Full Text] [Related]
20. Medicolegal issues arising when pacemaker and implantable cardioverter defibrillator devices are deactivated in terminally ill patients.
McGeary A; Eldergill A
Med Sci Law; 2010 Jan; 50(1):40-4. PubMed ID: 20349694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
